Genentech wins BARDA funds
Genentech wins BARDA funds is a scholarly work, published in 2018 in ''C&EN Global Enterprise''. The main subjects of the publication include medicine, business, cash, Pesticide toxicity to bees, medical emergency, and intensive care medicine. Some $19 million will go to develop alteplase, a drug already approved for heart attacks and stroke that shows promise in treating lung damage after mustard agent inhalation.